NEKTAR THERAPEUTICS — Director's Dealing 2013

Aug 7, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2013-08-05

Reporting Person: WHITFIELD ROY A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-08-05	Common Stock	M	12500	$11.41	Acquired	32500	Direct
2013-08-05	Common Stock	S	12500	$12.41	Disposed	20000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-08-05	Stock Option	$11.41	M	12500	Disposed	2013-09-03	Common Stock (12500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	20000	Indirect

Footnotes

F1: This transaction was made pursuant to a Rule 10b5-1 trading plan and the stock options exercised were scheduled to expire within 30 days of the date of this transaction.

F2: This holding represents a gift of shares by Mr. Whitfield to a trust for the benefit of Mr. Whitfield's children. Mr. Whitfield is the sole trustee of this trust.

F3: This stock option vests in equal monthly installments over one year commencing on September 4, 2003.